MicrobiologyAntiviral ResearchPeer-reviewed
RXR agonist S169 inhibits HBV/HDV entry in vitro by disrupting KIF4-dependent NTCP trafficking.
Sameh A. Gad, Doaa A Abo Elwafa, Saied A. Hussein…·Hussein Hassan Aly
This study identifies S169, an RXR agonist, as an inhibitor of HBV/HDV entry by disrupting KIF4-dependent NTCP trafficking in human hepatocytes.
3 citations